Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
192.67
-1.53 (-0.79%)
May 1, 2026, 4:00 PM EDT - Market closed

Quest Diagnostics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,27811,0359,8729,2529,88310,788
Revenue Growth (YoY)
11.03%11.78%6.70%-6.39%-8.39%14.32%
Cost of Revenue
7,5347,3706,6286,1996,4506,579
Gross Profit
3,7443,6653,2443,0533,4334,209
Selling, General & Admin
1,9951,9671,7701,6421,8741,727
Depreciation & Amortization Expenses
152154127108120103
Other Operating Expenses
-12-1214111-2
Total Operating Expenses
2,1352,1091,8981,7912,0051,828
Operating Income
1,6091,5561,3461,2621,4282,381
Interest Income
284219264478
Interest Expense
-260-264-201-152-138-151
Other Non-Operating Income (Expense)
27263020-55369
Total Non-Operating Income (Expense)
-205-196-152-106-149296
Pretax Income
1,4041,3601,1941,1561,2792,677
Provision for Income Taxes
329314273248264597
Net Income
1,0249928718549461,995
Minority Interest in Earnings
515450546985
Net Income to Common
1,0249928718549461,995
Net Income Growth
14.16%13.89%1.99%-9.72%-52.58%39.41%
Shares Outstanding (Basic)
111111111112116125
Shares Outstanding (Diluted)
113113113113118128
Shares Change (YoY)
-0.22%---4.24%-7.81%-5.88%
EPS (Basic)
9.178.877.787.598.1015.85
EPS (Diluted)
9.058.757.697.497.9715.55
EPS Growth
14.41%13.78%2.67%-6.02%-48.75%48.52%
Shares Outstanding
111110111111111119
Free Cash Flow
1,3261,3599098641,3141,830
Free Cash Flow Growth
-2.43%49.50%5.21%-34.25%-28.20%15.31%
Free Cash Flow Per Share
11.7912.038.047.6511.1414.30
Dividends Per Share
3.2603.2003.0002.8402.6402.480
Dividend Growth
1.88%6.67%5.63%7.58%6.45%10.71%
Gross Margin
33.20%33.21%32.86%33.00%34.74%39.02%
Operating Margin
14.27%14.10%13.63%13.64%14.45%22.07%
Profit Margin
9.53%9.48%9.33%9.81%10.27%19.28%
FCF Margin
11.76%12.32%9.21%9.34%13.30%16.96%
EBITDA
2,3332,1261,8391,7011,8652,789
EBITDA Margin
20.69%19.27%18.63%18.39%18.87%25.85%
EBIT
1,6091,5561,3461,2621,4282,381
EBIT Margin
14.27%14.10%13.63%13.64%14.45%22.07%
Effective Tax Rate
23.43%23.09%22.86%21.45%20.64%22.30%
Updated Apr 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q